Delivery Order SPE2DB24D9203-SPE2DB25FXBW5
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 29, 2025, for the supply of Mirena 52 mg systems. This firm fixed-price delivery order, valued at $2,603.85, represents a single issuance under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program. The contract involves no set-aside designation and is...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $3,645.39 by the Defense Logistics Agency (DLA) for Mirena 52 mg systems. This firm fixed-price delivery order, issued on August 4, 2025, with an ultimate completion date of August 25, 2025, represents a task order under the company's larger single-award Indefinite Delivery Contract with DLA valued at $499.999 billion and valid through...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $3,645.39 by the Defense Logistics Agency (DLA) on August 25, 2025, for the supply of Mirena 52 mg systems. This firm fixed-price delivery order, with an ultimate completion date of September 16, 2025, represents a discrete purchase under the company's larger Indefinite Delivery Contract with DLA valued at $499,999,999 and valid through...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order by the Defense Logistics Agency (DLA) for Mirena 52 mg systems, with a ceiling value of $1,041.56. The award, issued on August 6, 2025, represents a firm fixed-price delivery order with an ultimate completion date of August 27, 2025. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $26,038.50 by the Defense Logistics Agency (DLA) on August 29, 2025, for the supply of Mirena 52 mg systems. This firm fixed-price delivery order, which is scheduled for completion by September 22, 2025, was issued without a set-aside designation, allowing the contractor to compete on an unrestricted basis. The award represents a specific...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order award from the Defense Logistics Agency (DLA) on July 31, 2025, for the supply of Mirena 52 mg systems. This firm fixed-price delivery order, valued at $5,207.70 with an ultimate completion date of August 21, 2025, was issued without a set-aside designation. The award represents a task order under DMS Pharmaceutical Group's larger Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $5,207.70 by the Defense Logistics Agency for Mirena 52 mg systems. The award, issued on July 22, 2025, with an ultimate completion date of August 12, 2025, represents a firm fixed-price delivery order with no set-aside designation. This contract award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at approximately $12.5K by the Defense Logistics Agency (DLA) on July 25, 2025, for Mirena 52 mg systems with an ultimate completion date of August 15, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation. This award falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a firm fixed-price delivery order valued at $6,249.24 by the Defense Logistics Agency (DLA) for Mirena 52 mg systems. The contract, awarded on August 11, 2025, with an ultimate completion date of September 2, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $2,603.85 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order is set for ultimate completion by August 12, 2025, and represents a discrete purchase under the company's existing relationship with the DLA. This...
- SPE2DB24D9203Indefinite Delivery Contract
- SPE2DB24D9203-SPE2DB25FXBW5Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a firm fixed-price delivery order valued at $2,603.85 by the Defense Logistics Agency (DLA) for Mirena 52 mg systems. This delivery order, issued on May 30, 2025, with an ultimate completion date of June 23, 2025, represents a specific task order under the company's larger SPE2DB Indefinite Delivery Contract with DLA, valued at approximately $500 million and valid through November 2026. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on its merits as a federal contractor specializing in pharmaceutical supply to military and federal healthcare facilities. This delivery order exemplifies DMS Pharmaceutical Group's core role in the federal pharmaceutical supply chain, providing medical products to Department of Defense healthcare sites nationwide. The company's contract portfolio with DLA encompasses an extensive range of pharmaceutical items including prescription medications, biologics, vaccines, and medical consumables across multiple therapeutic categories. The modest value of this particular delivery order reflects the targeted nature of task orders issued against the master IDC, which enables DLA to efficiently procure specific pharmaceutical products to support military health facility operations with firm fixed pricing and predictable delivery timelines.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 5/30/25 |